Abstract
We have investigated the role of MSH2, a mismatch repair gene in cell proliferation, cell cycle control and cell invasiveness in the SW480 human colorectal cancer cell line. RNAi-mediated inhibition of MSH2 expression was achieved using MSH2 shRNA lentiviral expression vectors. Effective knockdown of endogenous MSH2 expression was determined by real-time PCR analysis. The most efficient MSH2 knockdown vector was selected for subsequent studies using SW480 cells. Endogenous MSH2 mRNA levels decreased after lentiviral delivery of the MSH2-RNAi, indicating efficient silencing of MSH2 expression in SW480 cells. Cell proliferation, cell cycle progression and cell invasiveness were quantified by MTT assays, flow cytometry and transwell assays, respectively. RNAi-mediated inhibition of MSH2 expression in SW480 cells resulted in decreased cell proliferation, cell cycle arrest at the G0/G1 phase and decreased cell invasiveness. Taken together, these results provide evidence that MSH2 stimulates cell proliferation, promotes cell cycle progression and positively regulates cell invasiveness.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lynch H T, Watson P, Shaw T G, et al. Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part II: Hereditary nonpolyposis colorectal carcinoma as a model. Cancer, 1999, 86: 2457–2463
Muller A, Edmonston T B, Corao D A, et al. Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res, 2002, 62: 1014–1019
Seifert M, Reichrath J. The role of the human DNA mismatch repair gene hMSH2 in DNA repair, cell cycle control and apoptosis: Implications for pathogenesis, progression and therapy of cancer. J Mol Histol, 2006, 37: 301–307
Charames G S, Bapat B. Genomic instability and cancer. Curr Mol Med, 2003, 3: 589–596
Muller A, Fishel R. Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest, 2002, 20: 102–109
Srivastava T, Chattopadhyay P, Mahapatra A K, et al. Increased hMSH2 protein expression in glioblastoma multiforme. J Neurooncol, 2004, 66: 51–57
Zhang H, Richards B, Wilson T, et al. Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res, 1999, 59: 3021–3027
Brown K D, Rathi A, Kamath R, et al. The mismatch repair system is required for S-phase checkpoint activation. Nat Genet, 2003, 33: 80–84
Li G M. The role of mismatch repair in DNA damage-induced apoptosis. Oncol Res, 1999, 11: 393–400
Stojic L, Brun R, Jiricny J. Mismatch repair and DNA damage signalling. DNA Repair, 2004, 3: 1091–1101
Lois C, Hong E J, Pease S, et al. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science, 2002, 295: 868–872
Van Oosten M, Stout G J, Backendorf C, et al. Mismatch repair protein Msh2 contributes to UVB-induced cell cycle arrest in epidermal and cultured mouse keratinocytes. DNA Repair, 2005, 4: 81–89
Chang D K, Goel A, Ricciardiello L, et al. Effect of H(2)O(2) on cell cycle and survival in DNA mismatch repair-deficient and -proficient cell lines. Cancer Lett, 2003, 195: 243–251
Wei X L, Ni H, Wang Q S, et al. Impact of STAT4 gene silencing on the expression profile of proteins in EL-4 cells. Chin Sci Bull, 2009, 54: 3265–3270
Bae-Jump V L, Zhou C, Boggess J F, et al. Synergistic effect of rapamycin and cisplatin in endometrial cancer cells. Cancer, 2009, 115: 3887–3896
Leach F S, Polyak K, Burrell M, et al. Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res, 1996, 56: 235–240
Adamson A W, Beardsley D I, Kim W J, et al. Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2. Mol Biol Cell, 2005, 16: 1513–1526
O’Brien V, Brown R. Signalling cell cycle arrest and cell death through the MMR system. Carcinogenesis, 2006, 27: 682–692
Campregher C, Luciani M G, Gasche C. Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells. Gut, 2008, 57: 780–787
Scherer S J, Maier S M, Seifert M, et al. p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UV. J Biol Chem, 2000, 275: 37469–37473
Pucciarelli S, Agostini M, Viel A, et al. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer. Dis Colon Rectum, 2003, 46: 305–312
Nijhuis E R, Nijman H W, Oien K A, et al. Loss of MSH2 protein expression is a risk factor in early stage cervical cancer. J Clin Pathol, 2007, 60: 824–830
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Shen, K., Ye, Y., Jiang, K. et al. MSH2 is required for cell proliferation, cell cycle control and cell invasiveness in colorectal cancer cells. Chin. Sci. Bull. 57, 2580–2585 (2012). https://doi.org/10.1007/s11434-012-5258-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-012-5258-0